During the past decade, U.O.C. Ematologia Ospedale "San Nicola Pellegrino" ASL BAT conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "U.O.C. Ematologia Ospedale "San Nicola Pellegrino" ASL BAT" are "ALL Ph Positive" (1 trials), "Follicular Lymphoma" (1 trials), "Leukemia" (1 trials) and "Mantle Cell Lymphoma" (1 trials). Many other conditions were trialed in "U.O.C. Ematologia Ospedale "San Nicola Pellegrino" ASL BAT" in a lesser frequency.

Most popular intervention types in "U.O.C. Ematologia Ospedale "San Nicola Pellegrino" ASL BAT" are "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Metabolic activity measured by FDG-PET" (1 trials), "Rituximab, Bendamustine, Cytarabine." (1 trials), "Total therapy approach" (1 trials), "asparaginase" (1 trials) and "cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "U.O.C. Ematologia Ospedale "San Nicola Pellegrino" ASL BAT" are 4 trials for "All" genders.

Currently, there are NaN active trials in "U.O.C. Ematologia Ospedale "San Nicola Pellegrino" ASL BAT". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in U.O.C. Ematologia Ospedale "San Nicola Pellegrino" ASL BAT, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in U.O.C. Ematologia Ospedale "San Nicola Pellegrino" ASL BAT, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".